Lethal weapons against cancer

Cancer treatments K*ll tumor cells—does it really matter how?

Cells can die or signal injury via several different biological processes or pathways, and research increasingly suggests that the particular mechanism activated by a cancer therapy can significantly affect treatment outcomes.

Join us as Koch Institute researchers explain how they are leveraging specific cell injury and cell death pathways to take out tumors using new approaches to improve immunotherapy response and target aggressive, metastatic cancer cells.

Assistant Professor of Biology

David H. Koch Professor of Science
Professor of Biology and Biological Engineering
Director, MIT Center for Precision Cancer Medicine

Tiffany Emmons, PhD
Postdoctoral Associate, Yaffe Laboratory

Host or Publisher The Koch Institute at MIT